Capital International, Inc. Legend Biotech Corp Transaction History
Capital International, Inc.
- $7.11 Billion
- Q1 2024
A detailed history of Capital International, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital International, Inc. holds 453,664 shares of LEGN stock, worth $26.6 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
453,664
Previous 432,216
4.96%
Holding current value
$26.6 Million
Previous $26 Million
2.15%
% of portfolio
0.36%
Previous 0.42%
Shares
14 transactions
Others Institutions Holding LEGN
# of Institutions
212Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$643 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$352 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$316 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$154 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$140 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $9.83B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...